Literature DB >> 12615721

Arf induces p53-dependent and -independent antiproliferative genes.

Mei-Ling Kuo1, Eric J Duncavage, Rose Mathew, Willem den Besten, Deqing Pei, Deanna Naeve, Tadashi Yamamoto, Cheng Cheng, Charles J Sherr, Martine F Roussel.   

Abstract

The tumor suppressor p19(Arf) (p14(ARF) in humans), encoded by the Ink4a/Arf locus, is mutated, deleted, or silenced in many forms of cancer. p19(Arf) induces growth arrest by antagonizing the activity of the p53-negative regulator, Mdm2, thereby inducing a p53 transcriptional response. p19(Arf) can also inhibit cell cycle progression of mouse embryo fibroblasts lacking Cip1 or lacking both Mdm2 and p53, although in the absence of p53, arrest occurs more slowly. Profiling with high-density oligonucleotide GeneChips and cDNA microarrays was used to interrogate mouse genes, the expression of which was induced or suppressed by a conditionally regulated Arf gene. Cluster analysis of temporal gene expression patterns and validation of the results by RNA analysis identified Arf-responsive genes whose induction was both p53-dependent and -independent. The latter included four members of the B-cell translocation gene family (Btg1, Btg2, Btg3, and Tob1) that were demonstrated to inhibit cell proliferation in primary mouse embryo fibroblasts expressing or lacking functional p53. Together, the results indicate that p19(Arf) induces a broad spectrum of proteins that likely act in concert to arrest cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615721

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

2.  Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage.

Authors:  Masataka Sugimoto; Adam Gromley; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

3.  A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Authors:  Alexander D Boiko; Sarah Porteous; Olga V Razorenova; Vadim I Krivokrysenko; Bryan R Williams; Andrei V Gudkov
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

4.  Release the ink4a/arf growth suppression by "u" and "me"?

Authors:  Shuo Qie; Nianli Sang
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

5.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

6.  Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.

Authors:  Olivier Ayrault; Frederique Zindy; Jerold Rehg; Charles J Sherr; Martine F Roussel
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

7.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

8.  Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Authors:  Frederique Zindy; Richard T Williams; Troy A Baudino; Jerold E Rehg; Stephen X Skapek; John L Cleveland; Martine F Roussel; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

9.  ARF represses androgen receptor transactivation in prostate cancer.

Authors:  Wenfu Lu; Yingqiu Xie; Yufang Ma; Robert J Matusik; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2013-02-28

10.  CCR4-associated factor CAF1 is an essential factor for spermatogenesis.

Authors:  Cyril Berthet; Anne-Marie Morera; Marie-Jeanne Asensio; Marie-Agnes Chauvin; Anne-Pierre Morel; Frederique Dijoud; Jean-Pierre Magaud; Philippe Durand; Jean-Pierre Rouault
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.